A nucleic acid amplification test-based strategy does not help inform return to work for healthcare workers with COVID-19.
Influenza Other Respir Viruses
; 16(5): 851-853, 2022 09.
Article
in English
| MEDLINE | ID: covidwho-1865100
ABSTRACT
OBJECTIVE:
The objective of this study is to assess the utility of a nucleic acid amplification test-based approach to shorten isolation of healthcare workers (HCWs) with COVID-19 in the setting of the highly transmissible omicron variant.METHODS:
Between December 24, 2021, and January 5, 2022, HCWs who tested positive for SARS-CoV-2 were retested with PCR at least 5 days since onset of symptoms.RESULTS:
Forty-six sequential fully COVID-19 vaccinated HCWs who had tested positive for SARS-CoV-2 underwent follow-up testing. All the samples were confirmed as omicron variants and only four (8.7%) were negative in the follow-up test performed at a median of 6 (range 5-12) since onset of symptoms.CONCLUSIONS:
Implementation of a test-based strategy is logistically challenging, increases costs, and did not lead to shorter isolation in our institution.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Cohort study
/
Prognostic study
Topics:
Vaccines
/
Variants
Limits:
Humans
Language:
English
Journal:
Influenza Other Respir Viruses
Journal subject:
Virology
Year:
2022
Document Type:
Article
Affiliation country:
Irv.13000
Similar
MEDLINE
...
LILACS
LIS